10 Things to Know About Microscopic Colitis and Chronic Diarrhea

Microscopic colitis is an inflammatory bowel condition that affects the large intestine and commonly causes persistent, watery diarrhea. Unlike other forms of colitis, the colon often appears normal during a colonoscopy. The inflammation can only be seen under a microscope after small tissue samples, called biopsies, are examined. Because of this, the condition may go undiagnosed unless biopsies are taken, even when digestive symptoms have lasted for weeks or months.

Although microscopic colitis is not the same as Crohn’s disease or ulcerative colitis, it can still have a significant impact on daily life. Frequent diarrhea, abdominal cramping, urgency, bloating, fatigue, and unintended weight loss may interfere with work, travel, sleep, and social activities.

The condition is more common in older adults, particularly women, and certain medications, smoking, autoimmune diseases, and genetic factors may increase the risk. This article explains 10 important things to know about microscopic colitis and chronic diarrhea, including its symptoms, causes, diagnosis, treatment options, and long-term outlook.

Defining the Core Paradox of the Disease

To understand what is microscopic colitis, one must look at the central paradox of the condition: a patient can experience severe, chronic inflammation while their primary diagnostic imaging test appears completely clear.

Microscopic colitis is a chronic inflammatory bowel disease (IBD) characterized by persistent, watery, non-bloody diarrhea. When a gastroenterologist performs a colonoscopy, the mucosal lining of the large intestine looks entirely healthy and normal to the naked eye. There are no visible ulcers, bleeding, or redness like those seen in Crohn’s disease or ulcerative colitis.

Because of this, a definitive micro colitis diagnosis cannot be made by visual inspection alone. The physician must collect multiple small tissue biopsies from various sections of the colon. A pathologist then stains and examines these samples under a microscope to reveal the hidden inflammation, allowing them to differentiate this condition from functional disorders like Irritable Bowel Syndrome (IBS).

The Microscopic Subtypes: Collagenous vs. Lymphocytic

Pathologists divide the disease into two primary microscopic subtypes based on the specific cellular changes found in the colon tissue. While they look different under a lens, both types share nearly identical symptoms and respond to the exact same medical treatments.

Collagenous Colitis: This type is defined by an abnormally thick band of collagen—the main structural protein in connective tissue—sitting just beneath the surface cells of the colon lining.

Lymphocytic Colitis: This type is marked by a significant increase in lymphocytes, a type of white blood cell, within the surface lining of the colon. While a small number of these immune cells live in the colon naturally, microscopic lymphocytic colitis causes their numbers to skyrocket to more than 20 lymphocytes per 100 surface cells. This heavy accumulation shows that the immune system is actively targeting the body’s own tissues, disrupting normal fluid balance and causing chronic diarrhea.

The Clinical Hallmark: Secretory Chronic Diarrhea

The primary symptom of microscopic colitis is chronic, watery, non-bloody diarrhea. This is not just occasional loose stool; it involves frequent, large-volume bowel movements that can start gradually or come on suddenly.

Immune Dysregulation ──► Active Electrolyte Secretion ──► Secretory Watery Diarrhea ──► Nocturnal Urgency

This persistent diarrhea is a defining feature of the condition, and its clinical patterns include:

Secretory Nature: The diarrhea in microcolitis is classified as a “secretory diarrhea.” This means the inflamed intestinal lining actively pumps salt and water into the bowel instead of absorbing it. Because of this mechanical malfunction, the diarrhea typically continues even if the patient fasts or avoids food.

High Frequency and Dehydration: Patients commonly experience four to ten watery bowel movements a day. In severe cases, this frequency can exceed ten episodes per day, leading to weight loss, dangerous dehydration, and electrolyte imbalances.

Nocturnal Diarrhea: A particularly challenging feature is waking up from sleep with an urgent need to use the bathroom. Nocturnal episodes are a strong indicator of an organic, physical disease rather than a functional issue like IBS, which rarely interrupts sleep.

Absence of Visible Blood: Because the surface lining does not develop deep, bleeding ulcers, the stool remains non-bloody. This key difference helps doctors distinguish micro colitis from ulcerative colitis, where rectal bleeding is common.

Co-Occurring Inflammatory Symptoms

Beyond watery stools, the widespread inflammation within the large intestine disrupts the normal contraction patterns of the bowel, leading to a cluster of related digestive symptoms:

• Abdominal Cramping and Pain: The colon walls experience intermittent spasms as they try to manage the excess fluid volume, causing mild-to-moderate cramping across the mid-to-lower abdomen.

• Bloating and Gas: The fluid shifts and altered cell function can slow down normal digestion, leading to uncomfortable pressure and visible abdominal distension.

• Fecal Urgency and Incontinence: The sudden rush of watery fluid into the rectum can create an intense, uncontrollable need to defecate. This symptom can be deeply disruptive, causing significant anxiety around travel, work, and social activities.

Overview of the Microscopic Colitis Profile

• What is Microscopic Colitis: A chronic inflammatory bowel disease of the large intestine that causes persistent watery diarrhea but leaves the colon looking normal during a standard visual colonoscopy.

• Microscopic Colitis Symptoms: Large-volume watery stools, night-time bowel movements, abdominal cramping, painful bloating, and intense fecal urgency without rectal bleeding.

• Micro Colitis Diagnosis: Achieved exclusively by taking multiple tissue biopsies throughout the colon and analyzing them under a microscope to look for dense collagen bands or elevated white blood cells.

Causes and Key Risk Factors for Microscopic Colitis

The precise causes of microscopic colitis remain unknown, but the condition is believed to result from an abnormal immune system response in genetically susceptible individuals, with key risk factors including the use of certain common medications, a strong association with other autoimmune disorders, and a distinct demographic profile favoring older women.

The Multifactorial Origins of Hidden Colon Inflammation

While the precise mechanisms remain the subject of ongoing medical research, microscopic colitis is widely understood to be an immune-mediated disorder. It arises from an abnormal, overactive inflammatory response in the large intestine of genetically susceptible individuals.

[Genetic Predisposition] + [Environmental Trigger] ──► Immune Dysregulation ──► Microscopic Colitis
                                                                     (Hidden Infiltration)

When patients ask what is microscopic colitis and what drives its development, clinicians point to a combination of internal and external factors. The condition does not stem from a single definitive source; instead, it occurs when an environmental trigger—such as a drug, bacterial toxin, or food antigen—disrupts the gut barrier in someone already predisposed to immune dysregulation.

This hidden inflammation alters how the colon manages fluids, turning an otherwise healthy-looking intestinal lining into a source of severe, chronic gastrointestinal distress.

Medication Triggers: A Leading Suspected Cause

A primary area of study regarding microscopic colitis causes focuses on the regular use of common, everyday medications. For many patients, a thorough review of their prescription and over-the-counter drug history is the most critical step in uncovering the root cause of their condition.

Observational data and clinical case reviews have strongly linked several drug classes to the development of microcolitis:

• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Widely used pain relievers are leading suspects. Long-term use can compromise the tight junctions of the colon wall, allowing antigens to leak into tissue and ignite inflammation.

• Proton Pump Inhibitors (PPIs): Medications frequently taken for acid reflux are significant triggers. They alter the chemical environment of the digestive tract, which can shift the gut microbiome and prompt an inflammatory reaction.

• Selective Serotonin Reuptake Inhibitors (SSRIs): Certain antidepressants are linked to altered gut motility and immune cell activation within the mucosal lining.

• Other Associated Agents: Cholesterol-lowering statins, specific blood pressure beta-blockers, and the diabetes medication acarbose are also known to trigger or worsen symptoms.

The Role of the “Drug Holiday”

Because medications are a leading answer to what causes microscopic colitis, gastroenterologists often recommend a supervised “drug holiday.” Under close medical guidance, a patient pauses the suspected medication. If their chronic diarrhea resolves during this trial period, it confirms a drug-induced cause, often eliminating the need for long-term immunosuppressive drugs.

The Autoimmune Network Connection

The development of microscopic lymphocytic colitis is deeply intertwined with the body’s broader autoimmune network. Rather than being an isolated intestinal issue, it is frequently part of a systemic pattern of immune dysregulation.

Systemic Autoimmune Predisposition ──► Mistaken Attack on Healthy Organs ──► Multi-System Involvement
                                                                               (Thyroid, Joints, Colon)

Individuals diagnosed with microscopic colitis have a significantly higher rate of co-existing autoimmune conditions compared to the general population. The most prominent links include:

• Celiac Disease: This is the strongest known association. Celiac disease is an autoimmune reaction to dietary gluten that damages the small intestine. The risk of developing hidden colon inflammation is up to 70 times higher in celiac patients.

• Thyroid Disorders: Autoimmune conditions like Hashimoto’s thyroiditis (underactive thyroid) and Graves’ disease (overactive thyroid) frequently appear alongside colon inflammation.

• Rheumatoid Arthritis & Type 1 Diabetes: These systemic conditions share similar genetic pathways of immune dysregulation, leaving the body vulnerable to attacking its own healthy tissues.

When evaluating these connections, clinicians note that tracking lymphocytic colitis symptoms alongside common microscopic colitis symptoms helps paint a complete picture of systemic immune dysfunction. This correlation guides doctors to screen for underlying conditions like celiac disease early in the care plan.

High-Risk Demographics: Age and Gender Bias

Epidemiological studies reveal a distinct demographic profile for those most likely to develop micro colitis, highlighting unique age and gender patterns:

Older Age Profile: The condition is most frequently diagnosed in individuals in their 60s and 70s, and is relatively rare in people under 45. This pattern suggests that years of cumulative exposure to environmental triggers, recurring mild infections, and long-term medication use eventually prompt the disease in vulnerable individuals.

Striking Female Predominance: Women face a significantly higher risk, with female-to-male diagnosis ratios ranging from 3:1 to as high as 7:1. The exact reason for this difference is still being studied, but it closely mirrors the female bias seen in other major autoimmune diseases. Researchers believe hormonal factors, such as estrogen’s complex effects on the immune system, play a major role.

Consequently, a typical profile for microscopic colitis symptoms female patients often includes a post-menopausal woman over 50 who presents with unexplained, severe, watery diarrhea. Additionally, lifestyle factors like cigarette smoking have been identified as potential risks that can accelerate the onset of the disease, particularly its collagenous subtype.

Achieving an Accurate Clinical Diagnosis

When these demographic factors and drug histories align, a physician will move forward with a formal evaluation to achieve a definitive micro colitis diagnosis.

Diagnostic Requirement Note: Because the surface of the bowel appears perfectly healthy during standard imaging, reaching a diagnosis relies entirely on a gastroenterologist gathering multiple tissue biopsies during a colonoscopy or flexible sigmoidoscopy.

[Clinical Suspicion] ──► Medication Review ──► Colonoscopy with Biopsies ──► Histopathology Confirmation

By identifying your specific risk factors, documenting your everyday medications, and looking closely at microscopic tissue samples, your medical team can rule out functional issues like Irritable Bowel Syndrome. This thorough process ensures you receive a highly accurate diagnosis and a targeted treatment plan to restore long-term gut health.

How is Microscopic Colitis Diagnosed and Distinguished from other conditions?

Microscopic colitis is definitively diagnosed through the histopathological examination of multiple random biopsies taken from a normal-appearing colon during a colonoscopy; it is distinguished from other gut disorders by its unique combination of chronic watery diarrhea, a visually normal colon, and the presence of specific microscopic inflammation.

The Diagnostic Workflow: Why Visual Inspection Fails

A standard visual colonoscopy is entirely insufficient on its own to secure a micro colitis diagnosis. During a visual exam, the mucosal lining of the large intestine typically appears smooth, pink, and perfectly healthy to the naked eye. At most, a gastroenterologist might notice minor, non-specific changes like slight redness or mild changes in blood vessel patterns, but nothing that signals structural disease.

Because the inflammation is completely invisible to the naked eye, a definitive diagnosis requires a specialized biopsy protocol during the colonoscopy:

Comprehensive Tissue Mapping: The gastroenterologist must take multiple random tissue biopsies (usually 8 to 10 samples) from several distinct segments throughout the entire large intestine, including the ascending, transverse, descending, and sigmoid colon.

Overcoming Patchy Inflammation: This extensive mapping is necessary because the microscopic inflammation can be patchy and uneven. If a doctor takes samples from only one area, they might accidentally miss the diseased tissue.

Histopathological Confirmation: A pathologist stains these tissue samples and examines them under a microscope. For collagenous colitis, they look for an abnormally thick subepithelial collagen band. For lymphocytic colitis, they look for a high concentration of intraepithelial lymphocytes. Without these physical samples, the true cause of a patient’s chronic diarrhea will be missed, which often leads to years of misdiagnosis.

Differentiating Microscopic Colitis from IBS and IBD

Reaching an accurate micro colitis diagnosis requires carefully distinguishing it from two other common gastrointestinal conditions: Irritable Bowel Syndrome (IBS) and classic Inflammatory Bowel Disease (IBD).

While their symptoms frequently overlap, their underlying causes, tissue appearances, and long-term outlooks are fundamentally different.

Microscopic Colitis vs. Irritable Bowel Syndrome (IBS)

The clinical presentation of microscopic colitis can closely mimic diarrhea-predominant IBS (IBS-D), as both conditions cause chronic loose stools, abdominal cramping, and sudden urgency. However, their underlying biology is completely different:

Functional vs. Organic: IBS is a functional disorder of gut-brain interaction. The bowel is overly sensitive and moves irregularly, but there is no structural damage or cellular inflammation. Both the visual colonoscopy and the microscopic biopsy from an IBS patient will come back entirely normal.

Key Clinical Clues: In contrast, microscopic colitis is an organic disease marked by measurable tissue inflammation. Key signs that point away from IBS and toward microscopic colitis include a sudden onset later in life (typically after age 50), large volumes of watery stool, and waking up during the night to pass stool (nocturnal diarrhea).

Microscopic Colitis vs. Inflammatory Bowel Disease (IBD)

While microscopic colitis falls under the broader category of inflammatory bowel conditions, it behaves much more mildly than classic IBD, which includes Crohn’s disease and ulcerative colitis:

Macroscopic Changes: Classic IBD causes severe, destructive inflammation that is highly visible during a colonoscopy. Doctors can easily see deep ulcers, raw erosions, and fragile tissue that bleeds at the slightest touch.

Clinical Symptoms: Patients with classic IBD frequently experience bloody stools, severe abdominal pain, high fevers, and significant weight loss. In contrast, the inflammation in microcolitis is strictly confined to the microscopic level, and the resulting diarrhea is completely non-bloody.

Long-Term Colon Cancer Risk: A critical difference between these conditions is your long-term health outlook. Years of severe inflammation from classic IBD significantly increase a patient’s risk of developing colorectal cancer, requiring frequent screening colonoscopies. Fortunately, microscopic colitis does not increase your long-term risk of colon cancer beyond that of the general population, providing a much more reassuring long-term outlook.

Comparative Diagnostic Indicators

The following matrix highlights the key differences across these three conditions, helping to explain why certain symptoms require an internal evaluation:

Summary of Key Diagnostic Distinctions

• What is Microscopic Colitis: A chronic inflammatory bowel condition characterized by persistent watery diarrhea, where the colon looks normal on a colonoscopy but shows clear inflammation under a microscope.

• Microscopic Colitis Symptoms: Key symptoms include large-volume watery stools, frequent night-time bowel movements, abdominal cramping, and an intense need to defecate without any blood in the stool.

• Lymphocytic Colitis Symptoms: Shares identical symptoms with the collagenous subtype, but is defined under a microscope by a heavy accumulation of white blood cells (lymphocytes) in the lining of the colon.

By combining a thorough review of your symptoms with targeted tissue mapping, your gastroenterologist can rule out functional issues like IBS and separate out more severe conditions like classic IBD. This careful approach ensures an accurate diagnosis and a clear path toward managing your condition effectively.

How is Chronic Diarrhea from Microscopic Colitis Managed and Treated?

The chronic diarrhea from microscopic colitis is managed using a stepwise, evidence-based approach that begins with conservative measures, such as identifying and eliminating potential triggers like medications, and progresses to highly effective pharmacological therapy, with the corticosteroid Budesonide being the cornerstone treatment for inducing remission.

First-Line Management Protocols

Managing chronic diarrhea from microscopic colitis begins with a clear, stepwise approach. For many patients, especially those with milder cases, making a few simple, everyday changes can calm the digestive tract without the need for powerful prescription drugs.

[Medication Review] ──► Stop NSAIDs/PPIs/SSRIs ──► Dietary Fine-Tuning ──► Over-the-Counter Control

When evaluating your initial treatment options, your medical team will typically focus on these core first-line strategies:

Supervised Medication Changes: This is the single most important initial step in managing microscopic colitis causes. Your doctor will carefully review your full list of prescriptions and over-the-counter supplements, looking for known triggers like NSAIDs, PPIs, or SSRIs. If a drug trigger is suspected, safely pausing that medication under medical supervision—and switching to a safe alternative—can completely resolve chronic diarrhea within a few weeks.

Targeted Dietary Modifications: While no single diet can cure microscopic colitis, adjusting what you eat can significantly ease your symptoms. Many patients find relief by avoiding common irritants like caffeine, alcohol, dairy products (lactose), artificial sweeteners, and heavily spiced or high-fat foods. Additionally, because there is a strong link between micro colitis and celiac disease, your doctor may recommend checking for gluten sensitivity or trying a temporary gluten-free diet.

Over-the-Counter Anti-Diarrheal Support: If your diarrhea persists after adjusting your medications and diet, over-the-counter options can provide effective symptom control. Loperamide helps reduce urgency and bowel frequency by gently slowing down gut motility. Bismuth subsalicylate is another helpful option, offering both anti-diarrheal support and mild anti-inflammatory properties to soothe the intestinal lining.

Advanced Medical Therapy: The Role of Budesonide

For patients with moderate-to-severe symptoms that do not respond to simple lifestyle changes, prescription therapy becomes necessary. The current gold standard for calming active tissue inflammation and achieving a definitive micro colitis diagnosis recovery is a specialized corticosteroid called Budesonide.

Budesonide is highly effective, with clinical trials showing that it helps roughly 80% of patients achieve complete symptom remission within 6 to 8 weeks of starting treatment.

While it belongs to the same family of powerful anti-inflammatory drugs as traditional steroids like prednisone, budesonide is uniquely engineered to target the gut. It features a specialized coating that allows it to pass safely through your stomach and small intestine, releasing the active medication directly into the colon where the hidden inflammation lives.

Furthermore, once it enters your bloodstream, about 90% of the drug is immediately broken down and cleared by your liver during its first pass. This localized, targeted design ensures that the medication calms tissue inflammation right where it is needed most, while sparing the rest of your body from the classic systemic side effects of steroids—such as sudden mood shifts, fluid retention, high blood sugar, or long-term bone density loss.

Tapering Protocols and Long-Term Care

A standard treatment plan to calm an active flare-up typically starts with a 9 mg daily dose of budesonide for 6 to 8 weeks. Once your bowel movements return to normal, your doctor will guide you through a gradual dose taper over several weeks rather than stopping the medication abruptly. This slow reduction allows your body to adjust safely.

[9mg Daily Induction (6-8 Weeks)] ──► Gradual Weekly Taper ──► Remission (Stop) OR Maintenance (3-6mg)

• Managing Symptom Relapse: While budesonide is incredibly effective at stopping an active flare-up, up to 60% of patients experience a return of their microscopic colitis symptoms after stopping the drug completely.

• Long-Term Maintenance Plans: If your chronic diarrhea returns after your initial treatment, your doctor may recommend a brief repeat course to calm the inflammation again. For individuals who experience frequent flare-ups, a low-dose long-term maintenance plan (such as 3 mg to 6 mg daily or every other day) may be used to safely keep lymphocytic colitis symptoms and watery stools under control over the long term.

Reaching Long-Term Clinical Remission

• What is Microscopic Colitis: A chronic inflammatory bowel disease where the colon appears normal during a standard colonoscopy but reveals clear tissue inflammation when biopsies are checked under a microscope.

• Microscopic Colitis Symptoms: Key warning signs include large volumes of watery stool, frequent night-time bowel movements, abdominal cramping, and sudden fecal urgency without rectal bleeding.

• Micro Colitis Diagnosis: Achieved by taking a series of small, random tissue samples from multiple segments of the large intestine to identify hidden white blood cell accumulation or thickened collagen bands.

By combining proactive medication reviews with targeted dietary adjustments and using gut-specific therapies like budesonide when needed, the vast majority of patients can successfully manage their symptoms, prevent sudden relapses, and enjoy a high quality of life.

What does long-term management of Microscopic Colitis involve?

Long-term management of Microscopic Colitis involves a comprehensive strategy combining medication to control inflammation, targeted dietary adjustments to minimize triggers, and vigilant monitoring for symptom relapses and associated conditions like bile acid malabsorption or celiac disease. Furthermore, this long-term approach aims to sustain remission and improve the patient’s overall quality of life by addressing the chronic and fluctuating nature of the condition.

Targeted Dietary Adjustments for Long-Term Control

While there is no single, universal diet to cure microscopic colitis, making specific dietary changes is a highly effective way to manage the disease long-term. The primary goal is to eliminate foods and beverages that irritate the colon wall or act as natural laxatives.

Eliminating Gut Stimulants: Removing caffeine and alcohol is a critical first step. Both substances naturally speed up gut motility and can trigger sudden spikes in microscopic colitis symptoms, turning mild irritation into a severe flare-up.

Managing Sugars and Artificial Sweeteners: High concentrations of simple sugars or artificial sweeteners (like sorbitol and mannitol found in sugar-free gums) have an osmotic effect. This means they draw excess water directly into the large intestine, worsening watery stools.

Tracking Hidden Intolerances: Lactose intolerance frequently co-exists with microcolitis. A temporary trial of a dairy-free or lactose-free diet can significantly reduce painful gas, bloating, and daily bowel frequency.

Uncovering Deeper Intestinal Triggers

Because the underlying microscopic colitis causes are heavily tied to immune system sensitivity, identifying personal food triggers is essential for long-term health:

• The Gluten Connection: Given the strong genetic link between microscopic lymphocytic colitis and celiac disease, many gastroenterologists recommend a strict gluten-free trial—especially for patients who continue to experience chronic diarrhea despite taking first-line medications.

• Utilizing a Food Diary: Logging your meals alongside daily bowel habits helps isolate personal triggers that might not appear on a standard medical list.

• The Low-FODMAP Approach: If you experience severe abdominal cramping and bloating alongside chronic loose stools, a temporary Low-FODMAP diet can help by restricting poorly absorbed, fermentable carbohydrates that feed gas-producing gut bacteria.

Prognosis: Is Microscopic Colitis Permanent?

When patients learn what is microscopic colitis, their next question is usually: Does it ever go away completely? The answer depends on how your individual body interacts with environmental triggers.

The Relapsing-Remitting Reality: For a small subset of patients, the condition may resolve completely after a single course of treatment and never return. However, for the majority of individuals, micro colitis follows a long-term, relapsing-remitting path. This means symptoms will disappear during treatment (remission) but can return weeks, months, or even years after stopping medication.

A Reassuringly Benign Long-Term Course: While managing a chronic condition requires ongoing patience, it is important to remember that this disease behaves much more mildly than classic IBD. It does not cause destructive tissue scarring, it does not require surgical bowel resections, and it does not increase your risk of colon cancer beyond that of the general population.

Sustaining Long-Term Remission: If you experience frequent relapses, your doctor will focus on maintaining calm in the gut. This may involve a low-dose maintenance plan using a gut-specific steroid like budesonide, or providing a clear protocol to restart your medication at the very first sign of a flare-up.

The Role of Bile Acid Malabsorption (BAM)

If your watery diarrhea persists despite taking standard anti-inflammatory medications, your medical team will look closely for other co-existing issues. A frequently overlooked cause of treatment-resistant diarrhea is Bile Acid Malabsorption (BAM).

Liver Generates Bile Acids ──► Enters Small Intestine ──► Reabsorption Fails in Ileum ──► Spills into Colon (Irritation & Diarrhea)

Bile acids are produced by your liver to help break down and digest fats. Normally, about 95% of these acids are reabsorbed in the final section of the small intestine (the terminal ileum) to be recycled. However, the tissue changes that occur with microscopic colitis can disrupt this recycling process, causing excess bile acids to spill over into the large intestine.

Once these acids hit the colon, they act as a powerful natural laxative, forcing the bowel walls to secrete high volumes of water and electrolytes. This causes a type of chronic diarrhea that looks identical to standard microscopic colitis symptoms female and male patients report.

• Securing a Diagnosis: When BAM is suspected, doctors can verify it using a specialized nuclear medicine test called a SeHCAT scan to measure how well your body retains bile acids, or by evaluating your response to targeted treatments.

• Targeted Treatment Options: When BAM complicates your recovery, standard anti-inflammatory drugs will not stop the diarrhea. Instead, your doctor will prescribe bile acid sequestrants (such as cholestyramine or colesevelam). These medications act as binders, locking onto the excess bile acids in your digestive tract and turning them into an inert compound that passes safely in your stool without irritating your colon.

Comparing Subtype Treatment: Collagenous vs. Lymphocytic

When a pathologist confirms a formal micro colitis diagnosis, they will classify the condition as either Collagenous Colitis or Lymphocytic Colitis. However, in daily clinical practice, this distinction is used primarily for classification rather than changing your treatment plan.

                      [Subtype Clinical Comparison]
                                    │
     ┌──────────────────────────────┴──────────────────────────────┐
     ▼                                                             ▼
[Collagenous Subtype Management]                              [Lymphocytic Subtype Management]
 ├── Addressed via symptom-severity scale                      ├── Addressed via symptom-severity scale
 ├── Uses budesonide as gold standard                          ├── Uses budesonide as gold standard
 └── May exhibit a slightly more persistent course              └── May show slightly higher spontaneous remission

Both variations of the disease are managed identically based on how severe your symptoms are, rather than what the cells look like under a microscope:

The Shared Treatment Pathway: For mild symptoms in both subtypes, initial care focuses on over-the-counter anti-diarrheals (like loperamide) and dietary adjustments. For moderate-to-severe cases of both collagenous and microscopic lymphocytic colitis, the gold standard first-line treatment remains a 6-to-8-week course of budesonide to quickly calm the underlying inflammation.

Minor Healing Variances: Some observational data suggests that patients tracking lymphocytic colitis symptoms may experience slightly higher rates of spontaneous remission (where symptoms clear up on their own without medication). In contrast, the collagenous subtype can sometimes follow a more persistent, medication-dependent path due to the thickened collagen band beneath the tissue lining.

Stepping Up Care When Needed: If either subtype fails to respond to budesonide, your gastroenterologist will follow the exact same backup plan. This includes exploring second-line options like immunomodulators or biologic medications to heal the tissue lining from the inside out.

By understanding how diet, lifestyle triggers, and co-existing issues like BAM interact with your body, you and your doctor can build a comprehensive, long-term care plan that keeps your gut calm and your digestion predictable.

Conclusion

Microscopic colitis is a treatable cause of chronic watery diarrhea, but it can be overlooked because the colon may appear normal during a routine colonoscopy. A diagnosis usually requires biopsies of the colon, allowing doctors to identify the inflammation that cannot be seen with the naked eye.

Treatment may involve medication changes, dietary adjustments, antidiarrheal medications, or prescription therapies that reduce inflammation. If diarrhea persists for several weeks, causes dehydration, leads to weight loss, or is accompanied by blood in the stool, severe abdominal pain, or fever, it is important to seek medical evaluation to determine the underlying cause and begin appropriate treatment.

Read morE: Bronchoscopy: Why It’s Done and What It Can Diagnose

Frequently Asked Questions

1. What is microscopic colitis?

Microscopic colitis is a type of inflammatory bowel disease that causes chronic, watery diarrhea due to inflammation in the lining of the colon. Unlike other forms of colitis, the colon usually looks normal during a colonoscopy. The diagnosis is made by examining biopsy samples under a microscope. There are two main types: collagenous colitis and lymphocytic colitis.

2. What are the symptoms of microscopic colitis?

The most common symptom of microscopic colitis is frequent, non-bloody watery diarrhea that may last for weeks or months. Other symptoms can include abdominal cramps, bloating, urgency to have a bowel movement, fecal incontinence, fatigue, and mild weight loss. Symptoms may come and go, with periods of improvement followed by flare-ups. Because these symptoms overlap with other digestive disorders, medical evaluation is needed for an accurate diagnosis.

3. What causes microscopic colitis?

The exact cause of microscopic colitis is not fully understood, but it is believed to involve an abnormal immune response in the colon. Certain medications, smoking, autoimmune diseases, infections, and genetic factors have all been linked to an increased risk. Some people develop symptoms after using nonsteroidal anti-inflammatory drugs (NSAIDs), proton pump inhibitors, selective serotonin reuptake inhibitors (SSRIs), or other medications. In many cases, no single cause can be identified.

4. How is microscopic colitis diagnosed?

Doctors usually diagnose microscopic colitis through a colonoscopy with multiple biopsies taken from different parts of the colon. Even if the colon appears healthy during the procedure, microscopic examination of the tissue can reveal the characteristic inflammation. Additional blood tests and stool tests may be performed to rule out infections or other causes of chronic diarrhea. A biopsy is essential because imaging and colonoscopy alone cannot confirm the diagnosis.

5. How is microscopic colitis treated?

Treatment for microscopic colitis depends on symptom severity and possible underlying triggers. Your doctor may recommend stopping medications that could be contributing to symptoms, making dietary changes, or using antidiarrheal medications. For moderate to severe disease, corticosteroids such as budesonide are often effective at reducing inflammation and controlling diarrhea. Some people may require additional medications if symptoms persist or recur.

6. Can microscopic colitis go away?

Many people with microscopic colitis experience periods of remission, especially with appropriate treatment. Some individuals improve after stopping medications that may have triggered the condition, while others need ongoing therapy to prevent flare-ups. Although relapses can occur, the condition does not usually increase the risk of colon cancer. Regular follow-up with a healthcare provider can help manage symptoms and adjust treatment if needed.

Sources

Mayo Clinic. Microscopic Colitis.
Cleveland Clinic. Microscopic Colitis. 
National Institute of Diabetes and Digestive and Kidney Diseases. Microscopic Colitis.
Crohn’s & Colitis Foundation. Microscopic Colitis.
Merck Manual Consumer Version. Microscopic Colitis.
MedlinePlus. Microscopic Colitis. 
American Gastroenterological Association. Clinical Practice Guideline on the Medical Management of Microscopic Colitis.